Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 20/20 | 0.81 |
| ▸ | CYP2C9 | P11712 | 5/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.68 |
| ▸ | CNR1 | P21554 | 1/20 | 0.68 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5079723 | 0.90 | CNR2 (1.00) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5212548 | 0.89 | CNR2 (0.93) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5213030 | 0.87 | CNR2 (1.00) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5214828 | 0.87 | CNR2 (0.96) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5215012 | 0.86 | CNR2 (0.98) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5214111 | 0.86 | CNR2 (0.98) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5250291 | 0.85 | CNR2 (0.81) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5079720 | 0.84 | CNR2 (0.75) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5215722 | 0.82 | CNR2 (0.78) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 | |
| SCHEMBL5212412 | 0.82 | CNR2 (0.85) | CNR2CYP2C9CYP2C19CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1565442-B1 | PYRIDINE DERIVATIVES AS CB2 RECEPTOR MODULATORS | GLAXO GROUP LTD (GB) | 2007-11-14 | — | — | EP | claimed |